John Parkinson

The latest CDC numbers show a 2.57% increase of measles cases from week-to-week. This is a significant decrease in the percentage of cases from last week where there was a 6.1% increase.

The latest CDC numbers show a 6.1% increase of measles cases from week-to-week. This is a slight increase in the percentage of cases from last week where there was a 5.92% increase.

In the second part of our conversation with the Peggy Lillis Foundation’s CEO Christian Lillis, he discusses the agenda for their annual visit to Capitol Hill to advocate for the most significant issues affecting people with C diff to members of Congress.

Peggy Lillis Foundation’s annual event will have a number of speakers addressing these Clostridioides difficile (C diff)-related issues as they look to draw awareness to shortcomings in both areas as well as others. The organization's CEO Christian John Lillis offers some insights around the upcoming meeting.

Stakeholders offer some insights around the challenges and potential solutions including a federal investment in the field.

In the final installment of the short series around fungal infections, Jatin Vyas, PhD, MD, discusses the challenges of developing antifungals.

In the second installment of the short series around fungal infections, Jatin Vyas, PhD, MD, discusses the increase in Candida auris including its unique clades and past challenges in diagnosing this difficult-to-treat infection.

Jatin Vyas, PhD, MD, discusses where the research is headed as it takes a page from the oncology world in trying to harness the immune system and combining with fungal therapeutics to treat these difficult infections.

The latest CDC numbers show a 5.92% increase of measles cases from week-to-week. This is a decrease in the percentage of cases from last week where there was a 9.18% increase.

Despite the federal government’s recent stance on pandemic planning, author Kevin Hazzard reminds us of the importance of public health work in this area.

In this episode, author Kevin Hazzard talks about the preflight logistics as well as other issues that needed to be corrected for successful transatlantic flights.

In our second episode of our series, author Kevin Hazzard discusses the measures needed to protect the pilots and medical staff on board the plane from contracting Ebola.

A small airline company with a cowboy mentality stepped up to become the first aviation company to fly American patients back to the US to receive treatment.

The latest CDC numbers show a 9.18% increase of measles cases from week-to-week. This is an increase in the number of cases from last week where there was a 6.3% increase.

In the final episode, the panelists offer some insights around following the federal agencies' ever-changing vaccine policies and the value of following professional medical societies' guidance during this period of uncertainty.

In this episode, the panelists discuss the potential concerns around changing vaccine guidelines and the importance of the American Academy of Pediatrics (AAP) stepping in to offer their recommendations.

In this episode, the panelists discuss the probability that with vaccine recommendations changing across states and federally, costs could shift to families and increase health disparities.

The latest CDC numbers show a 6.3% increase of measles cases from week-to-week. This is a decrease in the number of cases from last week where there was a 12.76% increase.

In this episode, the panelists talk about how they broach conversations with expectant mothers around counseling on vaccinations for their babies.

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted for a trivalent vaccine composition for use in the US, protecting against influenza A (H1N1 and H3N2) and influenza B (Victoria lineage).

In this episode, the panelists discuss how the pediatric immunization schedule changes could potentially influence vaccines' inequities, and how vaccine education continues to play a significant role in immunization uptake and improving health equity.

In this episode, the panel discusses the continued importance of getting all children vaccinated and the potential unintended consequences of fewer individuals being immunized if the current trends continue.

The latest CDC numbers show a 12.76% increase of measles cases from week-to-week. This is a slight decrease in the number of cases from last week where there was a 15.7% increase. The data also shows outbreaks in 3 new states.

Despite the absence of vaccine data to support making changes, the ACIP continues to alter the pediatric schedule that will see less children getting immunized against vaccine-preventable diseases.

In this episode of our roundtable discussion, the panelists talk about the changes to the CDC’s ACIP meetings.

As the US continues to undergo massive policy changes to the childhood vaccine schedule, clinicians and families are left uncertain on recommendations and guidance. Our roundtable looks to provide some insights and answer questions to some of the more pressing topics about this evolving issue.

A new modeling analysis shows the potential increases in cases, hospitalizations, deaths, as well as the healthcare costs associated with declining vaccination rates. Patricia Stinchfield, RN, MS, CPNP, offers commentary on the evolving measles outbreaks, discusses the vulnerable populations that are more at risk for contracting severe measles, and strategies to increase vaccination.

Patricia A Stinchfield, RN, MS, CPNP, discusses her medical experience caring for patients with it, and what fellow clinicians and the general public should know about less-discussed details and potential complications.

The latest CDC numbers show a 15.7% increase of measles cases from week-to-week. This is another large jump in cases, especially from last week where there was a 7.8% increase. The data also shows further outbreak spread across more states.

Eric Meissner, MD, PhD, discusses the takeaways of the ARTISTRY-2, phase 3 study, which compared bictegravir/emtricitabine/tenofovir alafenamide to bictegravir/lenacapavir in adults with HIV who were virologically suppressed.